Pasquale Notarstefano

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 296 citations · Full text

Thrombosis, Dose-finding Phase 2, Cardiovascular Disease +10

Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial

Paolo Della Bella, Francesca Baratto, Pasquale Vergara et al. · Circulation · 2022 · 170 citations

Radiofrequency Ablation of Atrial Fibrillation

Claudio Pratola, E. Baldo, Pasquale Notarstefano et al. · Circulation · 2007 · 106 citations · Full text

Electroanatomic and Pathologic Right Ventricular Outflow Tract Abnormalities in Patients With Brugada Syndrome

Maurizio Pieroni, Pasquale Notarstefano, Antonio Oliva et al. · Journal of the American College of Cardiology · 2018 · 90 citations

Brugada Syndrome, Cardiology

Multipoint pacing via a quadripolar left-ventricular lead: preliminary results from the Italian registry on multipoint left-ventricular pacing in cardiac resynchronization therapy (IRON-MPP)

Giovanni B. Forleo, Luca Santini, Massimo Giammaria et al. · EP Europace · 2016 · 83 citations · Full text